{A figure is presented}The Utility of Lens Culinaris Agglutinin-Reactive α-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma: Evaluation in a United States Referral Population

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 3, 2007, Pages 394-402

  Leerapun, Apinya ^a   Suravarapu, Sri V ^b   Bida, John P ^b   Clark, Raynell J ^b   Sanders, Elizabeth L ^b   Mettler, Teresa A ^a   Stadheim, Linda M ^a   Aderca, Ileana ^a   Moser, Catherine D ^a   Nagorney, David M ^b   LaRusso, Nicholas F ^a   de Groen, Piet C ^a   Menon, K V Narayanan ^a   Lazaridis, Konstantinos N ^a   Gores, Gregory J ^a   Charlton, Michael R ^a   Roberts, Rosebud O ^b   Therneau, Terry M ^b   Katzmann, Jerry A ^b   Roberts, Lewis R ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ; ALPHA FETOPROTEIN; DIAGNOSTIC AGENT; LENTIL LECTIN; PLANT LECTIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOANALYZER; CANCER DIAGNOSIS; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; FEMALE; HUMAN; LENTIL; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; TUMOR VOLUME; ADOLESCENT; BLOOD; CANCER INVASION; CASE CONTROL STUDY; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; METABOLISM; MIDDLE AGED; MORTALITY; NEEDLE BIOPSY; PATHOLOGY; PATIENT REFERRAL; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SURVIVAL; UNITED STATES;

ADOLESCENT; ADULT; AGED; ALPHA-FETOPROTEINS; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PLANT LECTINS; PROBABILITY; PROGNOSIS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 33947157637     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.12.005     Document Type: Article

References (26)

1. El-Serag H.B., Davila J.A., Petersen N.J., et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139 (2003) 817-823
2. El-Serag H.B., Mason A.C., and Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 33 (2001) 62-65
3. El-Serag H.B., Siegel A.B., Davila J.A., et al. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol 44 (2006) 158-166
4. Hayashi K., Kumada T., Nakano S., et al. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma. Am J Gastroenterol 94 (1999) 3028-3033
5. Okuda K., Tanaka M., Kanazawa N., et al. Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by Lens culinaris agglutinin-reactive alpha-fetoprotein. Int J Oncol 14 (1999) 265-271
6. Shiraki K., Takase K., Tameda Y., et al. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Hepatology 22 (1995) 802-807
7. Taketa K., Endo Y., Sekiya C., et al. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res 53 (1993) 5419-5423
8. Yamashita F., Tanaka M., Satomura S., et al. Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas. Gastroenterology 111 (1996) 996-1001
9. Hirai H., and Taketa K. Lectin affinity electrophoresis of alpha-fetoprotein: Increased specificity and sensitivity as a marker of hepatocellular carcinoma. J Chromatogr 604 (1992) 91-94
10. Song B.C., Suh D.J., Yang S.H., et al. Lens culinaris agglutinin-reactive alpha-fetoprotein as a prognostic marker in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. J Clin Gastroenterol 35 (2002) 398-402
11. Kamath P.S., Wiesner R.H., Malinchoc M., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33 (2001) 464-470
12. Yamagata Y., Shimizu K., Nakamura K., et al. Simultaneous determination of percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein and alpha-fetoprotein concentration using the LiBASys clinical auto-analyzer. Clin Chim Acta 327 (2003) 59-67
13. Marrero J.A., Su G.L., Wei W., et al. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients. Hepatology 37 (2003) 1114-1121
14. OPTN/UNOS Liver and Intestinal Organ Transplantation Committee Meeting. Modifications to the policy 3.6.4.4 (Liver Transplant Candidates with Hepatocellular Carcinoma [HCC]). Available at: http://www.optn.org/PoliciesandBylaws/policies/pdfs/policy_8.pdf. November 19, 2004.
15. Shimauchi Y., Tanaka M., Kuromatsu R., et al. A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients. Oncol Rep 7 (2000) 249-256
16. Sato Y., Nakata K., Kato Y., et al. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 328 (1993) 1802-1806
17. Hu K.Q., Kyulo N.L., Lim N., et al. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. Am J Gastroenterol 99 (2004) 860-865
18. Tsai S.L., Huang G.T., Yang P.M., et al. Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma. Hepatology 11 (1990) 481-488
19. Izuno K., Fujiyama S., Yamasaki K., et al. Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study. Hepatogastroenterology 42 (1995) 387-393
20. Nomura F., Ishijima M., Horikoshi A., et al. Determination of serum des-gamma-carboxy prothrombin levels in patients with small-sized hepatocellular carcinoma: comparison of the conventional enzyme immunoassay and two modified methods. Am J Gastroenterol 91 (1996) 1380-1383
21. Kuromatsu R., Tanaka M., and Tanikawa K. Serum alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein in patients with hepatocellular carcinoma. Liver 13 (1993) 177-182
22. Aoyagi Y., Mita Y., Suda T., et al. The fucosylation index of serum alpha-fetoprotein as useful prognostic factor in patients with hepatocellular carcinoma in special reference to chronological changes. Hepatol Res 23 (2002) 287
23. Kusaba T. Relationship between Lens culinaris agglutinin reactive alpha-fetoprotein and biological features of hepatocellular carcinoma. Kurume Med J 45 (1998) 113-120
24. Oka H., Saito A., Ito K., et al. Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein. J Gastroenterol Hepatol 16 (2001) 1378-1383
25. Kumada T., Nakano S., Takeda I., et al. Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. J Hepatol 30 (1999) 125-130
26. Sassa T., Kumada T., Nakano S., et al. Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma. Eur J Gastroenterol Hepatol 11 (1999) 1387-1392